Totals
- Total revenue
- $477,014
- Total expenses
- $470,020
- Contributions and grants received
- $0
- Grants paid
- $0
- Program service revenue
- $476,990
- Investment income
- $24
- Other revenue
- $0
- Total assets, end of year
- $611,679
- Total liabilities, end of year
- $215,943
- Net assets or fund balances, end of year
- $395,736
- Program services expenses (Part IX)
- $384,026
- Management and general expenses
- $85,994
- Fundraising expenses
- $0
- Program service expenses (Part III)
- $384,026
Program services were 81.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
2a · Program service revenue: RESTRICTED GOVERNMENT
total $381,569 · related or exempt $381,569
-
2b · Program service revenue: RESTRICTED GOVERNMENT
total $69,125 · related or exempt $69,125
-
2c · Program service revenue: UNRESTRICTED NON-GOVER
total $13,670 · related or exempt $13,670
-
2d · Program service revenue: NON-GOVERNMENT CLINICA
total $12,621 · related or exempt $12,621
-
2e · Program service revenue: OTHER REVENUE
total $5 · related or exempt $5
-
3 · Investment income
total $24 · excluded $24
Functional expenses
Part IX, the statement of functional expenses.
-
5 · Compensation of officers, directors and key employees
total $35,164 · management and general $35,164
-
7 · Other salaries and wages
total $188,456 · program services $188,676 · management and general -$220
-
9 · Other employee benefits
total $6,922 · program services $4,877 · management and general $2,045
-
10 · Payroll taxes
total $21,880 · program services $17,026 · management and general $4,854
-
11b · Fees: legal
total $435 · program services $435
-
11c · Fees: accounting
total $18,054 · management and general $18,054
-
11g · Fees: other
total $6,337 · management and general $6,337
-
12 · Advertising and promotion
total $4,500 · management and general $4,500
-
13 · Office expenses
total $3,932 · program services $1,908 · management and general $2,024
-
17 · Travel
total $3,246 · management and general $3,246
-
19 · Conferences, conventions and meetings
total $825 · management and general $825
-
22 · Depreciation, depletion and amortization
total $3,005 · management and general $3,005
-
23 · Insurance
total $2,855 · management and general $2,855
-
24a · Other expenses: SUBCONTRACTORS
total $161,734 · program services $161,734
-
24b · Other expenses: RESEARCH STIPENDS
total $9,370 · program services $9,370
-
24c · Other expenses: DUES AND SUBSCRIPTIONS
total $1,800 · management and general $1,800
-
24d · Other expenses: PERMITS, FEES, AND TAXE
total $1,505 · management and general $1,505
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $220,591 · end of year $126,040
-
2 · Savings and temporary cash investments
beginning of year $92,853 · end of year $110,251
-
4 · Accounts receivable
beginning of year $152,438 · end of year $364,281
-
9 · Prepaid expenses and deferred charges
beginning of year $1,257 · end of year $2,592
-
10a · Land, buildings and equipment: cost or other basis
$15,027
-
10b · Land, buildings and equipment: accumulated depreciation
$6,512
-
10c · Land, buildings and equipment, net
beginning of year $11,521 · end of year $8,515
-
17 · Accounts payable and accrued expenses
beginning of year $89,918 · end of year $215,943
-
27 · Net assets without donor restrictions
beginning of year $39,404 · end of year $1,088
-
28 · Net assets with donor restrictions
beginning of year $349,338 · end of year $394,648
Mission and programs · 2022
Mission
THE MISSION OF VISTAR, INC. IS TO ADVANCE THE RESEARCH AND EDUCATION MISSIONS OF THE DEPARTMENT OF VETERANS AFFAIRS BY PROVIDING A FLEXIBLE MECHANISM FOR THE RECEIPT AND ADMINISTRATION OF FUNDS, OTHER THAN VA APPROPRIATIONS, FOR THE CONDUCT OF APPROVED VA RESEARCH AND EDUCATION ACTIVITIES.
-
RESEARCH PROJECTSCALLAWAY; PREEMPT CRCPREVENTION OF COLORECTAL CANCER THROUGH A MULTIOMICS BLOOD TESTING.COOPER; INSIGHT COPDINTERVENTION STUDY IN OVERWEIGHT PATIENTS WITH COPD. COOPER; LABA/LAMA/ICSA 24-WEEK MULTI-CENTER, DOUBLE-BLIND, PLACEBO CONTROLLED DOSE-RANGE FINDING STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF ORAL QBW251 IN COPD PATIENTS ON TRIPLE INHALED THERAPY.DAS; PHASE II STUDYA PHASE II OPEN-LABEL, PARALLEL GROUP STUDY OF ABIRATERONE ACETATE PLUS PREDNISONE IN AFRICAN AMERICAN AND CAUCASIAN MEN WITH METASTATIC CASTRATE-RESISTANT PROSTATE CANCER.DAS; N-CCAPSNCI COVID-19 IN CANCER PATIENTS STUDY: A LONGITUDINAL NATURAL HISTORY STUDYDAS; NEOADAURAA PHASE III, RANDOMISED, CONTROLLED, MULTI-CENTRE, 3-ARM STUDY OF NEOADJUVANT OSIMERTINIB AS MONOTHERAPY OR IN COMBINATION WITH CHEMOTHERAPY VERSUS STANDARD OF CARE CHEMOTHERAPY ALONE FOR THE TREATMENT OF PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION POSITIVE, RESECTABLE NON-SMALL CELL LUNG CANCER.DELL'ITALIA; PHASE III STUDY TO ASSESS THE EFFICACY OF AD26.COV2.S FOR THE PREVENTION OF SARS-COV-2-MEDIATED COVID-19 IN ADULTS AGED 18 AND OLDER.DELL'ITALIA; PHASER: PHARMACOGENOMIC TESTING FOR VETERANSHAGE; PROMINENT - PEMAFIBRATE TO REDUCE CARDIOVASCULAR OUTCOMES BY REDUCING TRIGLYCERIDES IN PATIENTS WITH DIABETESMARKLAND; PRAGMATIC EVALUATION OF EVENTS AND BENEFITS OF LIPID-LOWERING IN OLDER ADULTS (PREVENTABLE) TRIALWELLS; A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY AND EFFICACY OF LIQUID ALPHA1-PROTEINASE INHIBITOR (HUMAN) PLUS STANDARD MEDICAL TREATMENT (SMT) VERSUS PLACEBO PLUS SMT IN HOSPITALIZED SUBJECTS WITH COVID-19
Expenses $384,026 · Revenue $476,990
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Louis J Dell'Italia MDLOUIS J DELL'ITALIA MD
PRESIDENT
- Total calculated
- $0
- Hours/week
- 4 + 40 related
-
J Allen Cooper MDJ ALLEN COOPER MD
VICE PRESIDENT
- Total calculated
- $0
- Hours/week
- 1 + 40 related
-
Susan Laing PhDSUSAN LAING PHD
TREASURER
- Total calculated
- $0
- Hours/week
- 1 + 40 related
-
Paul W Sanders MDPAUL W SANDERS MD
SECRETARY
- Total calculated
- $0
- Hours/week
- 1 + 40 related
-
Oladipo A Kukoyi MDOLADIPO A KUKOYI MD
COMMUNITY MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 40 related
-
Andrew SellersANDREW SELLERS
COMMUNITY MEMBER
- Total calculated
- $0
- Hours/week
- 1 + 40 related
-
Dina AveryDINA AVERY
EXECUTIVE DIRECTOR
- Total calculated
- $36,928
- From this org
- $35,164
- From related orgs
- $0
- Other
- $1,764
- Hours/week
- 40
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
No itemized grants to organizations on this return.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
501(C)(27) · AL
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 12 June 2023
- IRS schema version
- 2022v5.0
- Source object
- 202331919349301058
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.